Literature DB >> 26151271

Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.

Matthew R Cooperberg1, Peter R Carroll1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26151271     DOI： 10.1001/jama.2015.6036

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  202 in total

1.  Prostate cancer: Growth of AS in the USA signals reduction in overtreatment.

Authors:  Declan G Murphy; Stacy Loeb
Journal:  Nat Rev Urol       Date:  2015-09-22       Impact factor: 14.432

2.  Urological cancer: management of patients with prostate cancer: evolution towards a risk-stratified approach.

Authors:  Peter Sidaway
Journal:  Nat Rev Clin Oncol       Date:  2015-07-28       Impact factor: 66.675

3.  Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.

Authors:  Robert Steven Gerhard; Dattatraya Patil; Yuan Liu; Kenneth Ogan; Mehrdad Alemozaffar; Ashesh B Jani; Omer N Kucuk; Viraj A Master; Theresa W Gillespie; Christopher P Filson
Journal:  Urol Oncol       Date:  2017-01-12       Impact factor: 3.498

4.  Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer.

Authors:  Spyridon P Basourakos; John W Davis; Brian F Chapin; John F Ward; Curtis A Pettaway; Louis L Pisters; Neema Navai; Mary F Achim; Xuemei Wang; Hsiang-Chun Chen; Seungtaek Choi; Deborah Kuban; Patricia Troncoso; Sam Hanash; Timothy C Thompson; Jeri Kim
Journal:  BJU Int       Date:  2017-08-16       Impact factor: 5.588

5.  Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Authors:  William U Shipley; Wendy Seiferheld; Himanshu R Lukka; Pierre P Major; Niall M Heney; David J Grignon; Oliver Sartor; Maltibehn P Patel; Jean-Paul Bahary; Anthony L Zietman; Thomas M Pisansky; Kenneth L Zeitzer; Colleen A F Lawton; Felix Y Feng; Richard D Lovett; Alexander G Balogh; Luis Souhami; Seth A Rosenthal; Kevin J Kerlin; James J Dignam; Stephanie L Pugh; Howard M Sandler
Journal:  N Engl J Med       Date:  2017-02-02       Impact factor: 91.245

6.  Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.

Authors:  Amy N Luckenbaugh; Gregory B Auffenberg; Scott R Hawken; Apoorv Dhir; Susan Linsell; Sanjeev Kaul; David C Miller
Journal:  J Urol       Date:  2016-09-20       Impact factor: 7.450

7.  Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.

Authors:  J Kellogg Parsons; John P Pierce; James Mohler; Electra Paskett; Sin-Ho Jung; Michael J Morris; Eric Small; Olwen Hahn; Peter Humphrey; John Taylor; James Marshall
Journal:  BJU Int       Date:  2017-05-21       Impact factor: 5.588

8.  Active treatment in low-risk prostate cancer: a population-based study.

Authors:  S Roy; M E Hyndman; B Danielson; A Fairey; R Lee-Ying; W Y Cheung; A R Afzal; Y Xu; T Abedin; H C Quon
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 9.  Active surveillance for prostate cancer: current evidence and contemporary state of practice.

Authors:  Jeffrey J Tosoian; H Ballentine Carter; Abbey Lepor; Stacy Loeb
Journal:  Nat Rev Urol       Date:  2016-03-08       Impact factor: 14.432

Review 10.  Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.

Authors:  Stacy Loeb; Nataliya K Byrne; Binhuan Wang; Danil V Makarov; Daniel Becker; David R Wise; Herbert Lepor; Dawn Walter
Journal:  Eur Urol       Date:  2020-02-22       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.